|
Re: Great Presetation today
|
4
|
Zenith Epigenetics
|
Oct 18, 2017 06:20AM
|
|
Re: My latest email to IR
|
6
|
Resverlogix Corp.
|
Oct 18, 2017 12:54PM
|
|
American Society of Nephrology Kidney Week
|
8
|
Resverlogix Corp.
|
Oct 18, 2017 02:19PM
|
|
Re: Great Presetation today
|
4
|
Zenith Epigenetics
|
Oct 18, 2017 04:27PM
|
|
Re: Shareholder Rights Plan
|
3
|
Resverlogix Corp.
|
Oct 18, 2017 04:59PM
|
|
Re: Great Presetation today
|
3
|
Zenith Epigenetics
|
Oct 19, 2017 09:40AM
|
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 19, 2017 12:43PM
|
|
Re: Great Discussion
|
1
|
Resverlogix Corp.
|
Oct 19, 2017 01:06PM
|
|
Re: ESC 2017
|
5
|
Resverlogix Corp.
|
Oct 20, 2017 10:17AM
|
|
BET inhibitors in mCRPC
|
3
|
Zenith Epigenetics
|
Oct 20, 2017 01:41PM
|
|
Re: ... here's a little tidbit...
|
2
|
Resverlogix Corp.
|
Oct 20, 2017 05:09PM
|
|
Re: ... here's a little tidbit...
|
2
|
Resverlogix Corp.
|
Oct 20, 2017 05:23PM
|
|
Re: Bio Europe - Resverlogix Presenting
|
1
|
Resverlogix Corp.
|
Oct 21, 2017 07:58AM
|
|
Re: ClinicalTrials.Gov updated....calling the science geeks
|
2
|
Resverlogix Corp.
|
Oct 21, 2017 08:09AM
|
|
Q4 2017 Events
|
3
|
Resverlogix Corp.
|
Oct 21, 2017 08:14AM
|
|
Re: Great Presetation today
|
2
|
Zenith Epigenetics
|
Oct 21, 2017 11:36AM
|
|
ZEN-3694 mCRPC Trial Status
|
6
|
Zenith Epigenetics
|
Oct 24, 2017 11:18AM
|
|
Re: Science
|
7
|
Resverlogix Corp.
|
Oct 24, 2017 02:54PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
3
|
Zenith Epigenetics
|
Oct 24, 2017 04:55PM
|
|
Re: We might already be at 125 events....
|
5
|
Resverlogix Corp.
|
Oct 25, 2017 01:04PM
|
